An Observational Study of Patients With Primary Mitochondrial Disease (SPIMM-300)

NCT03048617 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 215

Last updated 2019-04-11

No results posted yet for this study

Summary

This is an observational study of patients with Primary Mitochondrial Disease with either signs or symptoms suggestive of myopathy. The Investigator will identify potential patients through existing medical records and one on-site visit.

Conditions

  • Primary Mitochondrial Disease

Sponsors & Collaborators

  • Stealth BioTherapeutics Inc.

    lead INDUSTRY

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-13
Primary Completion
2018-08-02
Completion
2019-03-07

Countries

  • United States
  • Australia
  • Canada
  • Denmark
  • Germany
  • Hungary
  • Italy
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03048617 on ClinicalTrials.gov